There were 117 press releases posted in the last 24 hours and 429,138 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Celldex Therapeutics Initiates Phase 1/2 Clinical Trial of New Product Candidate CDX-014 in Advanced Renal Cell Carcinoma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image